Date | 6/30/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $14,472.00 | $80,000.00 | $369,615.00 | $11,196.00 | $440,000.00 | $495,088.00 | $737,705.00 | $848,922.00 |
Accounts Receivable Net Current | -- | -- | -- | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Assets | $14,472.00 | $131,268.00 | $465,924.00 | $156,189.00 | $631,620.00 | $698,297.00 | $948,438.00 | $1,067,097.00 |
Property Plant and Equipement | -- | -- | -- | -- | -- | -- | -- | -- |
Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- | -- | -- | -- |
Other Assets | -- | -- | -- | -- | -- | -- | -- | -- |
Total Assets | $53,341,634.00 | $130,082,389.00 | $129,372,329.00 | $128,781,888.00 | $129,128,073.00 | $129,240,721.00 | $129,537,893.00 | $129,700,116.00 |
Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- |
Accrued Liabilities | -- | -- | -- | -- | -- | -- | -- | -- |
Total Current Liabilities | -- | $2,642,038.00 | $1,116,400.00 | $368,551.00 | $400,043.00 | $101,720.00 | $343,146.00 | $322,506.00 |
Long Term Debt | -- | -- | -- | -- | -- | -- | -- | -- |
Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- |
Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- |
Accumulated Deficit | $-4,539,620.00 | $-2,511,152.00 | $-1,066,404.00 | $-908,996.00 | $-594,303.00 | $-257,002.00 | $-195,073.00 | $-12,210.00 |
Total Stockholders' Equity | $-4,439,238.00 | $-2,510,770.00 | $-650,476.00 | $-212,362.00 | $288,660.00 | $699,631.00 | $5,000,001.00 | $5,000,001.00 |
Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- |
Total Liabilities and Equity | $53,341,634.00 | $130,082,389.00 | $129,372,329.00 | $128,781,888.00 | $129,128,073.00 | $129,240,721.00 | $129,537,893.00 | $129,700,116.00 |
Date | 6/30/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|---|---|---|
Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- |
Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- |
Research and Development | -- | -- | -- | -- | -- | -- | -- | -- |
Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- |
Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- |
Loss from Operations | $-1,056,135.00 | $-2,836,416.00 | $-1,258,708.00 | $-269,959.00 | $-686,419.00 | $-110,293.00 | $-182,786.00 | $-21,779.00 |
Loss Before Income Taxes | $47,727.00 | $-873,760.00 | $-69,265.00 | $-68,040.00 | -- | -- | -- | -- |
Earnings Per Share Basic | -- | -- | -- | -- | -- | $-0.02 | -- | -- |
Weighted Average Shares Basic | -- | -- | -- | -- | -- | 3,817,863 | -- | -- |
Earnings Per Share Diluted | -- | -- | -- | -- | -- | $-0.02 | -- | -- |
Weighted Average Shares Diluted | -- | -- | -- | -- | -- | 3,777,116 | -- | -- |
Common Stock Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 |
Common Stock Shares Outstanding | 3,817,863 | 3,817,863 | 3,817,863 | 3,817,863 | 3,817,863 | 3,817,863 | 4,242,325 | 4,224,039 |
Common Stock Value | $382.00 | $382.00 | $382.00 | $382.00 | $382.00 | $382.00 | $424.00 | $422.00 |
Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Shares Authorized | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- |
Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Share Price | -- | -- | -- | -- | -- | -- | -- | -- |